Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,404
Closed -$396K 46
2025
Q3
$396K Sell
1,404
-75
-5% -$21.8K 0.13% 42
2025
Q2
$413K Sell
1,479
-50
-3% -$14.2K 0.14% 42
2025
Q1
$476K Hold
1,529
0.17% 45
2024
Q4
$399K Buy
1,529
+350
+30% +$104K 0.14% 48
2024
Q3
$380K Hold
1,179
0.13% 51
2024
Q2
$368K Buy
+1,179
New +$346K 0.13% 49
2021
Q4
Sell
-1,631
Closed -$347K 71
2021
Q3
$347K Hold
1,631
0.12% 64
2021
Q2
$398K Hold
1,631
0.13% 62
2021
Q1
$406K Hold
1,631
0.14% 59
2020
Q4
$375K Hold
1,631
0.14% 59
2020
Q3
$415K Buy
+1,631
New +$404K 0.17% 59
2017
Q3
Sell
-10,447
Closed -$1.8M 53
2017
Q2
$1.8M Sell
10,447
-105
-1% -$17.1K 1% 36
2017
Q1
$1.73M Sell
10,552
-13,480
-56% -$2.24M 1.04% 35
2016
Q4
$3.51M Sell
24,032
-72
-0.3% -$10.8K 2.21% 17
2016
Q3
$4.02M Sell
24,104
-99
-0.4% -$16.7K 2.54% 13
2016
Q2
$3.68M Buy
24,203
+200
+0.8% +$31.1K 2.26% 18
2016
Q1
$3.6M Sell
24,003
-254
-1% -$37.7K 2.24% 17
2015
Q4
$3.94M Sell
24,257
-115
-0.5% -$18.1K 2.56% 15
2015
Q3
$3.37M Sell
24,372
-200
-0.8% -$31.5K 2.29% 14
2015
Q2
$3.77M Buy
24,572
+22
+0.1% +$3.52K 2.34% 13
2015
Q1
$3.92M Buy
24,550
+40
+0.2% +$6.3K 2.36% 11
2014
Q4
$3.9M Buy
+24,510
New +$3.82M 2.53% 11

Other funds holding AMGN

Hendley & Co's AMGN Position: Q4 2025 in Review

Hendley & Co sold out of Amgen (AMGN) in Q4 2025, closing a stake of 1,404 shares — an estimated $396K sold.

Hendley & Co first reported a position in AMGN in Q4 2014 and held it in 22 quarters. The position peaked at $4.02M in Q3 2016. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Hendley & Co reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Hendley & Co sold 1,404 Amgen shares in Q4 2025, an estimated $396K.
  • Hendley & Co first reported a position in Amgen in Q4 2014 and held it in 22 quarters.
  • Hendley & Co's Amgen position peaked at $4.02M in Q3 2016.
  • 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Hendley & Co's 13F filing for Q4 2025, filed 5 Feb 2026.